Stay updated on CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial
Sign up to get notified when there's something new on the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page.

Latest updates to the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page
- Check6 days agoChange DetectedThe record history now shows a new revision entry v3.4.3 and removes v3.4.2, updating the history metadata.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded the Study Status entry on 2026-02-06 and updated to Revision v3.4.2 on 2026-02-04, with the temporary government funding lapse notice removed.SummaryDifference1%

- Check41 days agoChange DetectedNotice about a lapse in government funding was added, explaining that some website functions may be delayed, and the page revision was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check49 days agoChange DetectedThe updates add a glossary toggle, color-highlight explanations, and a new Revision: v3.4.0 tag, with slight wording adjustments around No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check84 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history. The 'HHS Vulnerability Disclosure' footer link and the prior 'Revision: v3.3.2' entry were removed.SummaryDifference0.2%

- Check106 days agoChange DetectedThe record history now shows a new revision entry (v3.3.2) added and the previous revision (v3.3.1) removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CUE-101 Pre-Surgery or Chemoradiation in HPV16+ OPSCC Clinical Trial page.